C12N 2500/38
Vitamins
C12N2500/38 (Vitamins) appears on 803 US grants and 1,575 published applications in this corpus.
Search patents in C12N- Granted patents
- 803
- Published applications
- 1,575
- Assignees
- 801
- Inventors
- 3,067
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 10 | 0 |
| 1999 | 18 | 0 |
| 2000 | 9 | 0 |
| 2001 | 15 | 4 |
| 2002 | 16 | 34 |
| 2003 | 15 | 35 |
| 2004 | 11 | 32 |
| 2005 | 12 | 31 |
| 2006 | 13 | 21 |
| 2007 | 9 | 34 |
| 2008 | 11 | 33 |
| 2009 | 11 | 45 |
| 2010 | 14 | 53 |
| 2011 | 17 | 45 |
| 2012 | 25 | 42 |
| 2013 | 17 | 57 |
| 2014 | 22 | 39 |
| 2015 | 32 | 70 |
| 2016 | 47 | 87 |
| 2017 | 39 | 73 |
| 2018 | 49 | 82 |
| 2019 | 41 | 92 |
| 2020 | 56 | 79 |
| 2021 | 35 | 96 |
| 2022 | 39 | 80 |
| 2023 | 51 | 94 |
| 2024 | 52 | 128 |
| 2025 | 52 | 104 |
| 2026 | 33 | 85 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Method for producing cell sheet6 Oct 2026US 12,753,390 B2Kaneka Corporation
- Compositions and methods for increasing T cell function15 Sep 2026US 12,734,150 B2Ludwig Institute for Cancer Research
- Radial glia and astrocyte differentiation from human pluripotent stem cells8 Sep 2026US 12,729,367 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Production of a probiotic composition25 Aug 2026US 12,714,731 B2Blis Technologies Limited
- Production of a probiotic composition8 Oct 2026US 2026/0306558 A1Blis Technologies Limited
- In vitro culturing method for inducing ovarian follicles from fetal ovarian cells of primate8 Oct 2026US 2026/0308531 A1Kyoto University
- Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells1 Oct 2026US 2026/0297516 A1
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Composition for inducing direct differentiation of stem cells into corneal endothelial cells and method for inducing direct differentiation using same24 Sep 2026US 2026/0286295 A1The Asan Foundation
Most cited
By later US patents
- Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration549US 6,200,606 B1DePuy Orthopaedics, Inc. · 2001
- Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins500US 5,122,469 AGenentech, Inc. · 1992
- Serum-free, synthetic, completely chemically defined tissue culture media450US 4,657,866 A1987
- Serum-free cell culture medium and process for making same430US 4,560,655 AImmunex Corporation · 1985
- Repair of cartilage and bones372US 4,642,120 ARamot University Authority for Applied Research and Industrial Development Ltd. · 1987